Amarin flags new REDUCE-IT analyses for presentation at ESC Congress 2026

Reuters2026/08/24 12:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Amarin flagged new REDUCE-IT analyses for presentation at the ESC Congress 2026 in Munich on Aug. 28-31.
Data focus on adherence, long-term outcomes, and biomarkers tied to cardiovascular risk, aiming to clarify how icosapent ethyl may drive benefit.
Mechanistic work suggests EPA could support favorable vascular cell responses linked to lipoprotein(a), reinforcing the drug’s broader cardiovascular rationale.
Readouts are scheduled across late August sessions, keeping investor attention on incremental evidence rather than a new pivotal efficacy result.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amarin Corporation plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608240815PRIMZONEFULLFEED9814849) on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Amarin flags new REDUCE-IT analyses for presentation at ESC Congress 2026

You may also like

Crypto prices